Medical Plastics Market Report
RA07168
Medical Plastics Market by Product (Polyethylene (PE), Polypropylene (PP), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyphenylsulfone (PPSU), Polyethersulfone (PES), Polyethylenimine (PEI), Polymethyl Methacrylate (PMMA), and Others), Application (Medical Device Packaging, Medical Components, Orthopedic Implant Packaging, Orthopedic Soft Goods, Wound Care, Cleanroom Supplies, BioPharma Devices, Mobility Aids, Sterilization & Infection Prevention, Tooth Implants, Denture Base Material, Other Implants, and Others), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Medical Plastics Overview
Medical plastics are polymer materials specifically designed and used in various medical applications. They are crucial in healthcare settings where hygiene, safety, and biocompatibility are paramount. Medical plastics find extensive use in medical devices, equipment, and packaging. Examples include syringes, catheters, implants, surgical instruments, respiratory masks, and pharmaceutical packaging. They possess properties that allow for complex shaping, excellent mechanical performance, and sterilization without compromising integrity. Medical-grade plastics are also utilized in implants, prosthetics, dental applications, and drug delivery systems, offering biocompatibility, durability, and controlled release of medication. These materials undergo strict quality control and regulatory compliance processes to ensure patient safety. In summary, medical plastics provide essential solutions that meet the demanding requirements of the healthcare industry.
Global Medical Plastics Market Analysis
The global medical plastics market size was $50.41 billion in 2022 and is predicted to grow at a CAGR of 8.0%, by generating a revenue of $103.64 billion by 2032.
COVID-19 Impact on Global Medical Plastics Market
The COVID-19 pandemic had a profound impact on the medical plastics market. The worldwide healthcare sector experienced a phenomenal surge in medical supply and device demand, leading to an increased need for medical plastics. These materials, such as polypropylene, polystyrene, and polyethylene, are basic in manufacturing crucial medical equipment, including personal protective equipment (PPE), ventilator components, testing kits, syringes, and vials. The production of PPE, such as face masks, gloves, and protective gowns, heavily relied on medical plastics. However, the pandemic also caused disruptions in global supply chains, resulting in shortages of raw materials and components necessary for medical plastics production. Some industries shifted their manufacturing capabilities towards medical plastics to address the urgent need for medical supplies. Additionally, a heightened focus on sterilization and hygiene led to the development of antimicrobial medical plastics and advancements in materials and surface technologies. The pandemic also accelerated research and development efforts in industry, driving innovation in new materials and sustainability. Regulatory changes were implemented to ensure the safety and efficacy of medical devices, requiring manufacturers to adapt to evolving standards.
Increasing Demand in the Healthcare Industry to Drive the Market Growth
The medical plastics market is propelled by various factors contributing to its growth. Firstly, the healthcare industry's increasing demand for medical devices, equipment, and packaging materials made from plastics plays a significant role. As the population grows and chronic diseases become more predominant, the need for advanced medical care increases, driving demand for medical plastics. Technological advances in plastic materials and manufacturing techniques are also playing an imperative part in extending the market. These advances have led to the development of innovative medical devices and devices that display attractive properties such as light weight, durability, adaptability, biocompatibility and ease of sterilization. The shift from conventional materials such as glass and metals to plastics too contributes to the market growth, as plastics offer benefits such as lighter weight, progressed safety, and improved functionality. Additionally, the focus on infection control in healthcare has increased the demand for infection-resistant and antimicrobial plastics. Rising healthcare spending, especially in emerging markets, has further increased the need for medical grade plastics for applications such as medical packaging, drug delivery systems, implants and diagnostic tools.
Stringent Regulatory Requirements to Restrain the Market Growth
The medical plastics market faces several factors that restrain its growth. One significant factor is the stringent regulatory requirements imposed on medical-grade plastics, which demand extensive compliance and validation processes. The high development costs associated with research, testing, and validation are a barrier, making it difficult for smaller companies to enter the market. Additionally, the limited availability of materials with the necessary properties for medical applications hinders market growth. The complexity of manufacturing medical plastics with intricate designs and customizations increases production costs and lead times. The competitive landscape, dominated by established players, presents challenges for new entrants and smaller companies. The increasing emphasis on environmental sustainability raises concerns regarding traditional plastics and drives the demand for eco-friendly alternatives, impacting the medical plastics market. Volatility in raw material prices, long product development cycles, and product safety concerns further restrain the market. Economic factors such as fluctuations, healthcare spending patterns, and reimbursement policies also affect the demand for medical plastics.
Technological Advancements to Drive Excellent Opportunities
The medical plastics market presents numerous opportunities for growth and development. Rapid advancements in medical technology, such as minimally invasive procedures, 3D printing, and implantable devices, require specialized materials that offer high performance, biocompatibility, and sterilization capabilities. Medical plastics can fulfill these requirements, providing opportunities for innovation and development. With continuous increases in healthcare expenditure worldwide, there is a growing demand for cost-effective and efficient medical devices and equipment, where medical plastics excel. Additionally, the aging population and the associated rise in chronic diseases create a market for medical interventions and devices, further driving the need for medical plastics. The increasing awareness of healthcare-associated infections (HAIs) also creates opportunities for medical plastics with antimicrobial properties. Moreover, the focus on sustainability in healthcare leads to the development of eco-friendly medical plastics. Emerging markets in Asia-Pacific and Latin America offer untapped potential for medical plastics manufacturers. Furthermore, personalized medicine and point-of-care testing require specialized devices, which medical plastics can facilitate. Lastly, regulatory support ensures patient safety and quality standards, providing opportunities for compliant medical plastics manufacturers.
Global Medical Plastics Market Share, by Product, 2022
The polyphenylsulfone (PPSU) sub-segment accounted for the highest market share in 2022. Polyphenylsulfone (PPSU) has gained significant traction in medical plastics due to its exceptional properties. PPSU exhibits remarkable chemical resistance, making it ideal for medical applications where exposure to various cleaning agents and sterilization methods is daily. Its high-temperature stability allows it to withstand repeated steam sterilization cycles without deformation or loss of properties. PPSU also boasts excellent mechanical strength, including high tensile and flexural strength and good impact resistance, ensuring durability and long-term reliability for medical devices and equipment. Additionally, PPSU's transparency enables easy visual inspection and monitoring, while its biocompatibility makes it suitable for applications that come into contact with bodily tissues or fluids. The material's ability to be effectively sterilized through various methods, such as autoclaving, EtO sterilization, and gamma radiation, further adds to its appeal. However, the dominance of PPSU in the medical plastics market is subject to factors like evolving regulations, advancements in material science, and the emergence of alternative materials.
Global Medical Plastics Market Share, by Application, 2022
The medical components sub-segment accounted for the highest market share in 2022. Medical components have dominated the medical plastics market due to several key factors. Firstly, medical plastics offer material properties such as biocompatibility, flexibility, durability, and chemical resistance, making them ideal for various medical applications. Secondly, advancements in medical technology have driven to the improvement of complex and advanced medical devices, and plastics empower the miniaturization, precision, and usefulness required by these technologies. Thirdly, medical plastics are cost-effective, with lower manufacturing costs, easier processing, and reduced production time. They are also lighter in weight, reducing shipping costs and increasing convenience. Additionally, medical components made from plastics comply with stringent regulatory requirements, having undergone extensive testing and scrutiny. Plastics are also compatible with various sterilization methods, ensuring they can be effectively sterilized. Furthermore, plastics offer customizability and design flexibility, enabling manufacturers to create tailored medical components. Material innovations, such as bioabsorbable polymers, have expanded the application possibilities of medical plastics.
Global Medical Plastics Market Share, by Region, 2022
The North America medical plastics market generated the highest revenue in 2022. North America has emerged as a dominant medical plastics market due to several key factors. Technological advancements and a robust research and development infrastructure have allowed the region to lead in innovations within the medical industry. This has resulted in the development of advanced medical devices and equipment extensively utilizing medical plastics. Moreover, North America boasts a highly developed and advanced healthcare industry, with numerous hospitals, clinics, and healthcare facilities that require a wide range of plastic medical products. The stringent regulatory standards set by the U.S. Food and Drug Administration (FDA) and Health Canada upgrade the reputation of North American medical plastics, ensuring their safety and viability. These regulations inspire confidence among customers and attract them to choose North American medical plastics. With a strong manufacturing base and advanced manufacturing processes, the region efficiently produces and supplies medical plastics to meet the growing demand. Lastly, North America provides a favorable business environment with stable economies, skilled workforces, and well-established distribution networks.
Competitive Scenario in the Global Medical Plastics Market
Investment and agreement are common strategies followed by major market players. One of the leading market players in the industry is Evonik Industries AG. JeNaCell, an Evonik company, launched the wound dressing epicite® balance in the German market. Available from June 2023, the dressing is particularly suited and optimized for the treatment of chronic wounds with low to medium exudation, such as venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers and soft tissue lesions. epicite® balance comes in three different sizes and will be distributed through the company Coopmed ApS to hospitals and homecare centers.
Some of the leading medical plastics market players are Röchling SE & Co. KG, Nolato AB, Saint-Gobain Performance Plastics, SABIC, Orthoclastic Ltd, Eastman Chemical Company, Celanese Corporation, Dow, Tekni-Plex, Solvay S.A., HMC Polymers, ARAN BIOMEDICAL TEORANTA, Trelleborg AB, Avantor Inc, Trinseo, and Evonik Industries AG.
| Aspect | Particulars |
| Historical Market Estimations | 2020-2022 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Product |
|
| Segmentation by Application |
|
| Key Companies Profiled |
|
Q1. What is the size of the global medical plastics market?
A. The size of the global medical plastics market was over $50.41 billion in 2022 and is projected to reach $103.64 billion by 2032.
Q2. Which are the major companies in the medical plastics market?
A. Trinseo and Evonik Industries AG. are some of the key players in the global medical plastics market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The North America region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Agreement and investment are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more in R&D practices?
A. Röchling SE & Co. KG, Nolato AB, Saint-Gobain Performance Plastics, SABIC, Orthoclastic Ltd, and Eastman Chemical Company are the companies investing more in R&D activities for developing new products and technologies.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Medical Plastics Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Medical Plastics Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Medical Plastics Market, By Product
5.1. Overview
5.2 Engineering plastics
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 High performance plastics (HPP)
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Standard plastics
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Silicone
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Others
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Research Dive Exclusive Insights
5.7.1 Market attractiveness
5.7.2 Competition heatmap
-
6. Medical Plastics Market, By End Use
6.1. Overview
6.2 Medical disposables
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Prosthetics
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Medical instruments & tools
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Drug delivery
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
7. Medical Plastics Market, By Region
7.1 North America
7.1.1 U.S
7.1.1.1 Market size analysis, By Product, 2020-2027
7.1.1.2 Market size analysis, By End Use, 2020-2027
7.1.2 Canada
7.1.2.1 Market size analysis, By Product, 2020-2027
7.1.2.2 Market size analysis, By End Use, 2020-2027
7.1.3 Mexico
7.1.3.1 Market size analysis, By Product, 2020-2027
7.1.3.2 Market size analysis, By End Use, 2020-2027
7.1.4 Research Dive Exclusive Insights
7.1.4.1 Market attractiveness
7.1.4.2 Competition heatmap
7.2 Europe
7.2.1 Germany
7.2.1.1 Market size analysis, By Product, 2020-2027
7.2.1.2 Market size analysis, By End Use, 2020-2027
7.2.2 UK
7.2.2.1 Market size analysis, By Product, 2020-2027
7.2.2.2 Market size analysis, By End Use, 2020-2027
7.2.3 France
7.2.3.1 Market size analysis, By Product, 2020-2027
7.2.3.2 Market size analysis, By End Use, 2020-2027
7.2.4 Spain
7.2.4.1 Market size analysis, By Product, 2020-2027
7.2.4.2 Market size analysis, By End Use, 2020-2027
7.2.5 Italy
7.2.5.1 Market size analysis, By Product, 2020-2027
7.2.5.2 Market size analysis, By End Use, 2020-2027
7.2.6 Rest of Europe
7.2.6.1 Market size analysis, By Product, 2020-2027
7.2.6.2 Market size analysis, By End Use, 2020-2027
7.2.7 Research Dive Exclusive Insights
7.2.7.1 Market attractiveness
7.2.7.2 Competition heatmap
7.3 Asia-Pacific
7.3.1 China
7.3.1.1 Market size analysis, By Product, 2020-2027
7.3.1.2 Market size analysis, By End Use, 2020-2027
7.3.2 Japan
7.3.2.1 Market size analysis, By Product, 2020-2027
7.3.2.2 Market size analysis, By End Use, 2020-2027
7.3.3 India
7.3.3.1 Market size analysis, By Product, 2020-2027
7.3.3.2 Market size analysis, By End Use, 2020-2027
7.3.4 Australia
7.3.4.1 Market size analysis, By Product, 2020-2027
7.3.4.2 Market size analysis, By End Use, 2020-2027
7.3.5 South Korea
7.3.5.1 Market size analysis, By Product, 2020-2027
7.3.5.2 Market size analysis, By End Use, 2020-2027
7.3.6 Rest of Asia-Pacific
7.3.6.1 Market size analysis, By Product, 2020-2027
7.3.6.2 Market size analysis, By End Use, 2020-2027
7.3.7 Research Dive Exclusive Insights
7.3.7.1 Market attractiveness
7.3.7.2 Competition heatmap
7.4 LAMEA
7.4.1 Brazil
7.4.1.1 Market size analysis, By Product, 2020-2027
7.4.1.2 Market size analysis, By End Use, 2020-2027
7.4.2 Saudi Arabia
7.4.2.1 Market size analysis, By Product, 2020-2027
7.4.2.2 Market size analysis, By End Use, 2020-2027
7.4.3 UAE
7.4.3.1 Market size analysis, By Product, 2020-2027
7.4.3.2 Market size analysis, By End Use, 2020-2027
7.4.4 South Africa
7.4.4.1 Market size analysis, By Product, 2020-2027
7.4.4.2 Market size analysis, By End Use, 2020-2027
7.4.5 Rest of LAMEA
7.4.5.1 Market size analysis, By Product, 2020-2027
7.4.5.2 Market size analysis, By End Use, 2020-2027
7.4.6 Research Dive Exclusive Insights
7.4.6.1 Market attractiveness
7.4.6.2 Competition heatmap
8. Competitive Landscape
8.1 Top winning strategies, 2020-2027
8.1.1 By strategy
8.1.2 By year
8.2 Strategic overview
8.3 Market share analysis, 2020-2027
9. Company Profiles
9.1 SABIC (Saudi Arabia)
9.1.1 Overview
9.1.2 Business segments
9.1.3 Product portfolio
9.1.4 Financial performance
9.1.5 Recent developments
9.1.6 SWOT analysis
9.2 BASF (Germany)
9.2.1 Overview
9.2.2 Business segments
9.2.3 Product portfolio
9.2.4 Financial performance
9.2.5 Recent developments
9.2.6 SWOT analysis
9.3 Celanese (US)
9.3.1 Overview
9.3.2 Business segments
9.3.3 Product portfolio
9.3.4 Financial performance
9.3.5 Recent developments
9.3.6 SWOT analysis
9.4 Evonik (Germany)
9.4.1 Overview
9.4.2 Business segments
9.4.3 Product portfolio
9.4.4 Financial performance
9.4.5 Recent developments
9.4.6 SWOT analysis
9.5 Solvay (Belgium)
9.5.1 Overview
9.5.2 Business segments
9.5.3 Product portfolio
9.5.4 Financial performance
9.5.5 Recent developments
9.5.6 SWOT analysis
9.6 and Covestro (Germany)
9.6.1 Overview
9.6.2 Business segments
9.6.3 Product portfolio
9.6.4 Financial performance
9.6.5 Recent developments
9.6.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
